Baron Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Sell
3,422
-47
-1% -$10.1K 0.22% 60
2026
Q1
$755K Buy
3,469
+1,028
+42% +$228K 0.23% 61
2025
Q4
$558K Buy
2,441
+663
+37% +$151K 0.17% 89
2025
Q3
$412K Buy
1,778
+132
+8% +$26.9K 0.14% 111
2025
Q2
$305K Sell
1,646
-677
-29% -$126K 0.11% 139
2025
Q1
$487K Sell
2,323
-325
-12% -$63.2K 0.21% 78
2024
Q4
$471K Buy
2,648
+29
+1% +$5.33K 0.22% 71
2024
Q3
$517K Buy
2,619
+331
+14% +$61.8K 0.25% 63
2024
Q2
$392K Sell
2,288
-364
-14% -$60.3K 0.2% 76
2024
Q1
$483K Buy
2,652
+712
+37% +$123K 0.26% 58
2023
Q4
$301K Buy
1,940
+250
+15% +$36.4K 0.16% 107
2023
Q3
$252K Buy
1,690
+94
+6% +$13.8K 0.16% 110
2023
Q2
$215K Buy
1,596
+2
+0.1% +$293 0.14% 125
2023
Q1
$254K Sell
1,594
-94
-6% -$14.4K 0.18% 103
2022
Q4
$273K Buy
+1,688
New +$259K 0.21% 91

Other funds holding ABBV

Baron Wealth Management's ABBV Position: Q2 2026 in Review

Baron Wealth Management reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $10.1K and leaving 3,422 shares worth $861K. The position accounts for 0.22% of the portfolio, ranked #60.

Baron Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,265 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Baron Wealth Management held 3,422 shares of AbbVie worth $861K as of Q2 2026.
  • Baron Wealth Management sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
  • AbbVie made up 0.22% of Baron Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Baron Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 1,265 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.